[Close]
- This page was created by volunteers like you!
- Help us make it even better. To learn more about contributing to MEpedia, click here.
- Join the movement
- Visit #MEAction to find support or take action. Donate today to help us improve and expand this project.
- Congratulations!
- MEpedia has got over 30 million views as of August 2022!
Tricyclic antidepressant
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
A tricyclic antidepressant is a type of antidepressant named for its three-ringed chemical structure.[1] Tricyclic antidepressants can be an effective treatment for depression but are less commonly used now that alternatives with fewer side effects exist.[1] However, they remain a good option if those treatments are not effective in a given case.[1]
Approved tricyclic antidepressants[edit | edit source]
As of June 2016, the FDA has approved the following tricyclic antidepressants to treat depression:[1]
- Amitriptyline
- Amoxapine
- Desipramine (Norpramin)
- Doxepin
- Imipramine (Tofranil)
- Nortriptyline (Pamelor)
- Protriptyline (Vivactil)
- Trimipramine (Surmontil)
Use in ME[edit | edit source]
Tricyclic antidepressants such as amitriptyline or clomipramine are commonly used in ME/CFS to treat chronic pain and to aid regular sleep.[citation needed]
See also[edit | edit source]
References[edit | edit source]
- ↑ Jump up to: 1.0 1.1 1.2 1.3 "Tricyclic antidepressants (TCAs)". Mayo Clinic. Retrieved January 9, 2019.
